Charles River Laboratories International Inc
XMUN:RV6
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Charles River Laboratories International Inc
XMUN:RV6
|
US |
|
C
|
Continental AG
F:CON
|
DE |
|
Health Catalyst Inc
F:2YP
|
US |
|
G
|
Greggs PLC
XMUN:41G1
|
UK |
|
R
|
REN Redes Energeticas Nacionais SGPS SA
F:RN4
|
PT |
|
R
|
Rexel SA
XMUN:E7V
|
FR |
|
Grindrod Ltd
OTC:GRDLF
|
ZA |
|
Swisscom AG
F:SWJ
|
CH |
|
F
|
Fiserv Inc
F:FIV
|
US |
|
J
|
Jiangsu Expressway Co Ltd
F:JE2
|
CN |
|
R
|
Reinet Investments SCA
XMUN:RNT
|
LU |
|
K
|
Kao Corp
XMUN:KAO
|
JP |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is RV6's stock price target?
Price Target
270.7
EUR
According to Wall Street analysts, the average 1-year price target for 
RV6 is 270.7 EUR with a low forecast of 130.28 EUR and a high forecast of 297.24 EUR.
What is the Revenue forecast for Charles River Laboratories International Inc?
Projected CAGR
4%
Over the last 13 years, the compound annual growth rate for Revenue has been 10%. The projected CAGR for the next 8 years is 4%.
What is the Gross Profit forecast for Charles River Laboratories International Inc?
Projected CAGR
4%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 10%. The projected CAGR for the next 8 years is 4%.
What is the Operating Income forecast for Charles River Laboratories International Inc?
Projected CAGR
15%
Over the last 13 years, the compound annual growth rate for Operating Income has been 9%. The projected CAGR for the next 5 years is 15%.